Atlas Trials

Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification

Clinical trial NCT06612944 · RECRUITING

Trial details

NCT number
NCT06612944
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes, Adult
Start date
2024-11-12
Primary completion
2027-11-12
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.